Patient experiences of interprofessional collaboration and intersectoral communication in rare disease healthcare in Germany - a mixed-methods study.
Healthcare
Intersectoral collaboration
Patient satisfaction
Quality of care
Rare disease
Journal
Orphanet journal of rare diseases
ISSN: 1750-1172
Titre abrégé: Orphanet J Rare Dis
Pays: England
ID NLM: 101266602
Informations de publication
Date de publication:
13 May 2024
13 May 2024
Historique:
received:
21
12
2023
accepted:
05
05
2024
medline:
14
5
2024
pubmed:
14
5
2024
entrez:
13
5
2024
Statut:
epublish
Résumé
Rare diseases are often complex, chronic and many of them life-shortening. In Germany, healthcare for rare diseases is organized in expert centers for rare diseases. Most patients additionally have regional general practicioners and specialists for basic medical care. Thus, collaboration and information exchange between sectors is highly relevant. Our study focuses on the patient and caregiver perspective on intersectoral and interdisciplinary care between local healthcare professionals (HCPs) and centers for rare diseases in Germany. The aims were (1) to investigate patients' and caregivers' general experience of healthcare, (2) to analyse patients' and caregivers' perception of collaboration and cooperation between local healthcare professionals and expert centers for rare diseases and (3) to investigate patients' and caregivers' satisfaction with healthcare in the expert centers for rare diseases. In total 299 individuals of whom 176 were patients and 123 were caregivers to pediatric patients participated in a survey using a questionnaire comprising several instruments and constructs. Fifty participants were additionally interviewed using a semistructured guideline. Most patients reported to receive written information about their care, have a contact person for medical issues and experienced interdisciplinary exchange within the centers for rare diseases. Patients and caregivers in our sample were mainly satisfied with the healthcare in the centers for rare diseases. The qualitative interviews showed a rather mixed picture including experiences of uncoordinated care, low engagement and communication difficulties between professionals of different sectors. Patients reported several factors that influenced the organization and quality of healthcare e.g. engagement and health literacy in patients or engagement of HCPs. Our findings indicate the high relevance of transferring affected patients to specialized care as fast as possible to provide best medical treatment and increase patient satisfaction. Intersectoral collaboration should exceed written information exchange and should unburden patients of being and feeling responsible for communication between sectors and specialists. Results indicate a lack of inclusion of psychosocial aspects in routine care, which suggests opportunities for necessary improvements.
Sections du résumé
BACKGROUND
BACKGROUND
Rare diseases are often complex, chronic and many of them life-shortening. In Germany, healthcare for rare diseases is organized in expert centers for rare diseases. Most patients additionally have regional general practicioners and specialists for basic medical care. Thus, collaboration and information exchange between sectors is highly relevant. Our study focuses on the patient and caregiver perspective on intersectoral and interdisciplinary care between local healthcare professionals (HCPs) and centers for rare diseases in Germany. The aims were (1) to investigate patients' and caregivers' general experience of healthcare, (2) to analyse patients' and caregivers' perception of collaboration and cooperation between local healthcare professionals and expert centers for rare diseases and (3) to investigate patients' and caregivers' satisfaction with healthcare in the expert centers for rare diseases.
RESULTS
RESULTS
In total 299 individuals of whom 176 were patients and 123 were caregivers to pediatric patients participated in a survey using a questionnaire comprising several instruments and constructs. Fifty participants were additionally interviewed using a semistructured guideline. Most patients reported to receive written information about their care, have a contact person for medical issues and experienced interdisciplinary exchange within the centers for rare diseases. Patients and caregivers in our sample were mainly satisfied with the healthcare in the centers for rare diseases. The qualitative interviews showed a rather mixed picture including experiences of uncoordinated care, low engagement and communication difficulties between professionals of different sectors. Patients reported several factors that influenced the organization and quality of healthcare e.g. engagement and health literacy in patients or engagement of HCPs.
CONCLUSIONS
CONCLUSIONS
Our findings indicate the high relevance of transferring affected patients to specialized care as fast as possible to provide best medical treatment and increase patient satisfaction. Intersectoral collaboration should exceed written information exchange and should unburden patients of being and feeling responsible for communication between sectors and specialists. Results indicate a lack of inclusion of psychosocial aspects in routine care, which suggests opportunities for necessary improvements.
Identifiants
pubmed: 38741100
doi: 10.1186/s13023-024-03207-9
pii: 10.1186/s13023-024-03207-9
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
197Informations de copyright
© 2024. The Author(s).
Références
European Union. Regulation (EC) N°141/2000 of the European Parliament and of the Council of 16 December 1999 on orphan medicinal products… 2000 14.08.2022]; http://eurlex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2000:018:0001:0005:EN:PDF
Nguengang Wakap S, et al. Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database. Eur J Hum Genet. 2020;28(2):165–73.
doi: 10.1038/s41431-019-0508-0
pubmed: 31527858
Haendel M, et al. How many rare diseases are there? Nat Rev Drug Discovery. 2020;19(2):77–8.
doi: 10.1038/d41573-019-00180-y
pubmed: 32020066
Vicente E, Pruneda L, Ardanaz E. Regarding the estimations of people affected by rare diseases. Eur J Hum Genet. 2021;29(6):1032–3.
doi: 10.1038/s41431-020-00763-z
pubmed: 33262443
Gunne E, et al. An estimate of the cumulative paediatric prevalence of rare diseases in Ireland and comment on the literature. Eur J Hum Genet. 2022;30(11):1211–5.
doi: 10.1038/s41431-022-01144-4
pubmed: 35853949
pmcid: 9626478
Zurynski Y, et al. Australian children living with rare diseases: experiences of diagnosis and perceived consequences of diagnostic delays. Orphanet J Rare Dis. 2017;12(1):68.
doi: 10.1186/s13023-017-0622-4
pubmed: 28399928
pmcid: 5387276
Austin CP, et al. Future of Rare diseases Research 2017–2027: an IRDiRC perspective. Clin Transl Sci. 2018;11(1):21–7.
doi: 10.1111/cts.12500
pubmed: 28796445
von der Lippe C, Neteland I, Feragen KB. Children with a rare congenital genetic disorder: a systematic review of parent experiences. Orphanet J Rare Dis. 2022;17(1):375.
doi: 10.1186/s13023-022-02525-0
pubmed: 36253830
pmcid: 9575260
NAMSE. Nationaler Aktionsplan für Menschen mit seltenen Erkrankungen. 2013 24.11.2022]; https://www.bundesgesundheitsministerium.de/fileadmin/Dateien/3_Downloads/N/NAMSE/Nationaler_Aktionsplan_fuer_Menschen_mit_Seltenen_Erkrankungen_-_Handlungsfelder__Empfehlungen_und_Massnahmenvorschlaege.pdf
Hebestreit H. Centers for rare diseases-Structures, tasks and networks. Gefasschirurgie: Z fur Vaskulare und Endovaskulare Chirurgie : Organ Der Deutschen Und Der Osterreichischen Gesellschaft fur Gefasschirurgie Unter Mitarbeit Der Schweizerischen Gesellschaft fur Gefasschirurgie. 2021;26(8):577–82.
24.11.2022]. https://www.clarcert.com/systeme/namse/news/start-des-neuen-zertifizierungssystem-fur-namse-typ-a-zentren-fur-seltene-erkrankungen.html
se-atlas: Kartenansicht mit Versorgungseinrichtungen. 08.09.2022].
Thiel R. # SmartHealthSystems Digitalisierungsstrategien Im Internationalen Vergleich. Bertelsmann Stiftung; 2018.
Reitzle L, et al. Perceived Access to Health Care Services and Relevance of Telemedicine during the COVID-19 pandemic in Germany. Int J Environ Res Public Health. 2021;18(14):7661.
doi: 10.3390/ijerph18147661
pubmed: 34300110
pmcid: 8303178
Pauer F, et al. [Healthcare services for people in Lower Saxony (Germany) suffering from a rare disease: findings from a survey among medical professionals]. Z Evid Fortbild Qual Gesundhwes. 2016;113:36–44.
doi: 10.1016/j.zefq.2016.05.003
pubmed: 27480187
Kripalani S, et al. Deficits in communication and information transfer between hospital-based and primary care physicians: implications for patient safety and continuity of care. JAMA. 2007;297(8):831–41.
doi: 10.1001/jama.297.8.831
pubmed: 17327525
Smits RM, et al. Common needs in uncommon conditions: a qualitative study to explore the need for care in pediatric patients with rare diseases. Orphanet J Rare Dis. 2022;17(1):153.
doi: 10.1186/s13023-022-02305-w
pubmed: 35379257
pmcid: 8981675
Baumbusch J, Mayer S, Sloan-Yip I. Alone in a crowd? Parents of children with rare diseases’ experiences of navigating the Healthcare System. Journal of Genetic Counseling; 2018.
Pasquini TL, Goff SL, Whitehill JM. Navigating the US health insurance landscape for children with rare diseases: a qualitative study of parents’ experiences. Orphanet J Rare Dis. 2021;16(1):1–14.
doi: 10.1186/s13023-021-01943-w
Inhestern L, et al. Interface management concepts in healthcare for rare diseases in Germany: a study protocol for a mixed-methods study to develop best practice recommendations. BMJ Open. 2020;10(11):e040470.
doi: 10.1136/bmjopen-2020-040470
pubmed: 33257484
pmcid: 7705519
Winkler J, Stolzenberg H. Adjustierung Des Sozialen-Schicht-Index für die Anwendung Im Kinder-Und Jugendgesundheitssurvey (KiGGS). Wismarer Diskussionspapiere; 2009.
Scholl I, et al. Fragebogen Zur Zufriedenheit in Der Ambulanten versorgung–schwerpunkt patientenbeteiligung (ZAPA). Klinische Diagnostik und Evaluation. 2011;4(1):50–62.
Schmidt J, Wittman W. Fragebogen zur Messung der Patientenzufriedenheit–ZUF-8 Bengel, J., Wirtz, M. & Zwingmann,. C, Herausgeber: Diagnostische Verfahren in der Rehabilitation (S. 255–258). Göttingen, Hogrefe, 2008.
Mayring P. Qualitative content analysis: theoretical foundation, basic procedures and software solution 2014.
Simpson A, et al. How are patients with rare diseases and their carers in the UK impacted by the way care is coordinated? An exploratory qualitative interview study. Orphanet J Rare Dis. 2021;16(1):76.
doi: 10.1186/s13023-020-01664-6
pubmed: 33568181
pmcid: 7874609
Walton H, et al. Development of models of care coordination for rare conditions: a qualitative study. Orphanet J Rare Dis. 2022;17(1):49.
doi: 10.1186/s13023-022-02190-3
pubmed: 35164822
pmcid: 8843018
von der Lippe C, Diesen PS, Feragen KB. Living with a rare disorder: a systematic review of the qualitative literature. Mol Genet Genomic Med. 2017;5(6):758–73.
doi: 10.1002/mgg3.315
pubmed: 29178638
pmcid: 5702559
Garrino L, et al. Living with and treating rare diseases: experiences of patients and professional health care providers. Qual Health Res. 2015;25(5):636–51.
doi: 10.1177/1049732315570116
pubmed: 25667160
Byrne N, et al. The role of primary care in management of rare diseases in Ireland. Ir J Med Sci (1971 -). 2020;189(3):771–6.
doi: 10.1007/s11845-019-02168-4
Brandt F, Salm F. Management Komplexer Behandlungsbedarfe durch patientenlotsen–eine qualitative Studie Zur Erfassung Des Status quo in Der GKV. Gesundheitsökonomie Qualitätsmanagement. 2022;27(01):46–54.
doi: 10.1055/a-1652-9623
Kenny T, Bogart K, Freedman A, Garthwaite C, Henley SMD, Bolz-Johnson M, Mohammed S, Walton J, Winter K, Woodman D. The importance of psychological support for parents and caregivers of children with a rare disease at diagnosis. Rare Disease Orphan Drugs J. 2022;1(2):7.
doi: 10.20517/rdodj.2022.04
Ward AJ, et al. Designing rare disease care pathways in the Republic of Ireland: a cooperative model. Orphanet J Rare Dis. 2022;17(1):162.
doi: 10.1186/s13023-022-02309-6
pubmed: 35410222
pmcid: 8996209